Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia

Completed · Not applicable

Conditions studied: Adrenal Hyperplasia, Congenital

In brief

The purpose of this study is to develop a more physiological approach to the management of children and adolescents with salt wasting Congenital Adrenal Hyperplasia. We will administer the glucocorticosteroid via insulin infusion pump to see whether this treatment will improve the serum hormone concentrations.

Key facts

Study ID

NCT00529841

Run by

Baylor College of Medicine

People needed

7

Starts

2007-01-01

Expected to finish

2008-09-01

Last updated by the study team

2015-09-14

Who can join

Age: 3 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children with salt wasting CAH otherwise healthy without other chronic disease
• Age: between 3 and 18 years of age
• Body weight 23 kg (50 lbs) or above
• Hemoglobin equal to or higher than 12 g/dl before the study
• Supportive family environment

You may not qualify if…

• Age less than 3 or older than 18 years at the time of study
• Other chronic disease
• Hemoglobin less than 12 g/dl
• Non-supportive family
• Allergy to local anesthetics
• Criteria for study termination: If the subject's parents are unable to manage/operate the pump, the subject will be withdrawn from the study.

Where it is running

• BCM, Texas Children's Hospital Clinic and General Clinical Research Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.